Podcast: Beyond AI: Why patient-centric clinical trials matter now
Research driving the development of new treatments involves several stakeholders: research coordinators, contract research organisations (CROs), and, most importantly, patients,…
Analysis
Osaka has the science. Now it needs the business
A practical framework for choosing e-signatures in global trials
ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of HER2-positive advanced gastric cancer
ZENBEXUS (iberdomide) for the Treatment of Multiple Myeloma, US
Sustaining long-term follow-up in cell and gene therapies
ICH GCP Annex 2 will strengthen sponsor confidence in the use of DCTs and RWD
Podcast: Bringing diversity to Alzheimer’s trials
